How big is the Nuclear Medicine Radioisotopes Market?

The Nuclear Medicine Radioisotopes Market size is expected to reach USD 6.26 billion in 2024 and grow at a CAGR of 10.35% to reach USD 10.25 billion by 2029. Read More

What is the current Nuclear Medicine Radioisotopes Market size?

In 2024, the Nuclear Medicine Radioisotopes Market size is expected to reach USD 6.26 billion. Read More

Who are the key players in Nuclear Medicine Radioisotopes Market?

NTP Radioisotopes SOC Ltd, Bayer AG, GE Healthcare, Nordion Inc. (Sotera Health Company) and Cardinal Health Inc. are the major companies operating in the Nuclear Medicine Radioisotopes Market. Read More

Which is the fastest growing region in Nuclear Medicine Radioisotopes Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Nuclear Medicine Radioisotopes Market?

In 2024, the North America accounts for the largest market share in Nuclear Medicine Radioisotopes Market. Read More

What years does this Nuclear Medicine Radioisotopes Market cover, and what was the market size in 2023?

In 2023, the Nuclear Medicine Radioisotopes Market size was estimated at USD 5.61 billion. The report covers the Nuclear Medicine Radioisotopes Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Nuclear Medicine Radioisotopes Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the key factors driving the growth of the global Nuclear Medicine Radioisotopes Market?

The key factors driving the growth of the global Nuclear Medicine Radioisotopes Market are a) Increased public awareness about nuclear medicine and its role in early disease detection can encourage more patients to seek these procedures b) The development of new medical facilities, especially in emerging economies, creates opportunities for wider access to nuclear medicine procedures Read More

What are the key factors driving the growth of the global Nuclear Medicine Radioisotopes Market?

The key factors driving the growth of the global Nuclear Medicine Radioisotopes Market are a) Increased public awareness about nuclear medicine and its role in early disease detection can encourage more patients to seek these procedures b) The development of new medical facilities, especially in emerging economies, creates opportunities for wider access to nuclear medicine procedures Read More

Nuclear Medicine Radioisotopes Market Share

Statistics for the 2023 & 2024 Nuclear Medicine Radioisotopes market share, created by Mordor Intelligence™ Industry Reports. Nuclear Medicine Radioisotopes share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

~~$4750~~

Team License

~~$5250~~

Corporate License

~~$8750~~

Buy Now

Book before:

Market Share of Nuclear Medicine Radioisotopes Industry

The nuclear medicine radioisotopes market is moderately competitive, with high competition. The market players are adopting various strategies such as product launches mergers and acquisition to expand the market share. The key players operating in the market include NTP Radioisotopes SOC Ltd, Bayer AG, GE Healthcare, Nordion Inc. (Sotera Health Company), and Cardinal Health Inc.

Nuclear Medicine Radioisotopes Market Leaders

NTP Radioisotopes SOC Ltd
Bayer AG
GE Healthcare
Nordion Inc. (Sotera Health Company)
Cardinal Health Inc.

*Disclaimer: Major Players sorted in no particular order

Nuclear Medicine Radioisotopes Market Share

Market Share of Nuclear Medicine Radioisotopes Industry

Nuclear Medicine Radioisotopes Market Leaders

Nuclear Medicine Radioisotopes Market Report Snapshots

Nuclear Medicine Radioisotopes Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)